Michel Gardet

Director/Board Member at Phagenesis Ltd.

68 year

Health Technology

Profile

Michel Gardet is currently a Director at Phagenesis Ltd.
He was formerly a Director at Glycom A and Global Head-Business Operations at Nestle Health Science SA.

Michel Gardet active positions

Companies	Position	Start
Phagenesis Ltd. Phagenesis Ltd. Pharmaceuticals: MajorHealth Technology Phagenesis Ltd. develops a treatment for dysphagia. Its product Phagenyx consists of a base station and a treatment catheter which in combination enable the healthcare professional to deliver personalized dysphagia treatment for every patient. The company was founded by Conor Joseph Mulrooney and Shaheen Hamdy in 2007 and is headquartered in Manchester, the United Kingdom.	Director/Board Member	-

All active positions of Michel Gardet

Former positions of Michel Gardet

Companies	Position	End
Nestle Health Science SA Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Nestle Health Science SA develops nutritional therapies. Its health management services include aging, brain health, chronic medical conditions, critical care and surgery, food allergy, gastro intestinal, metabolic diseases, and obesity pediatrics. The company was founded in 2011 and is headquartered in Vevey, Switzerland.	Chief Operating Officer	-
Glycom A/S Glycom A/S BiotechnologyHealth Technology Glycom A/S engages in the development, synthesis, and commercialization of human milk oligosaccharides. It develops chemical and enzymatic technologies for synthesis of human milk oligosaccharide powders. The company was founded by Gyuala Dekany, Mark von Itzstein, Joachim Erich Thiem, Arnold Stutz, and Inge Lundt on March 22, 2005 and is headquartered in Horsholm, Denmark.	Director/Board Member	-

See the detail of Michel Gardet's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michel Gardet's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Glycom A/S Glycom A/S BiotechnologyHealth Technology Glycom A/S engages in the development, synthesis, and commercialization of human milk oligosaccharides. It develops chemical and enzymatic technologies for synthesis of human milk oligosaccharide powders. The company was founded by Gyuala Dekany, Mark von Itzstein, Joachim Erich Thiem, Arnold Stutz, and Inge Lundt on March 22, 2005 and is headquartered in Horsholm, Denmark.	Health Technology
Nestle Health Science SA Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Nestle Health Science SA develops nutritional therapies. Its health management services include aging, brain health, chronic medical conditions, critical care and surgery, food allergy, gastro intestinal, metabolic diseases, and obesity pediatrics. The company was founded in 2011 and is headquartered in Vevey, Switzerland.	Health Technology
Phagenesis Ltd. Phagenesis Ltd. Pharmaceuticals: MajorHealth Technology Phagenesis Ltd. develops a treatment for dysphagia. Its product Phagenyx consists of a base station and a treatment catheter which in combination enable the healthcare professional to deliver personalized dysphagia treatment for every patient. The company was founded by Conor Joseph Mulrooney and Shaheen Hamdy in 2007 and is headquartered in Manchester, the United Kingdom.	Health Technology

See company connections

Stock Market
Insiders
Michel Gardet